Achieving the malaria MDG target: reversing the incidence of malaria 2000–2015

In 2000, malaria was identified as one of the biggest impediments to global development and selected as a critical global target of the Millennium Development Goals (MDGs). Target 6c aimed to halt and begin to reverse the incidence of malaria by 2015.

This report summarizes the remarkable progress seen, on a global and regional level, in reversing malaria mortality and incidence since 2000. It introduces malaria and the strategies used to fight the disease, outlines progress according to each of the MDG indicators, and highlights the main challenges that remain in controlling and eliminating this disease.

Between 2000 and 2015, malaria incidence fell by 37% globally and death rates by 60%. However, serious bottlenecks remain in providing full access to malaria prevention, diagnostic testing and treatment. Progress has been uneven, with some countries carrying a disproportionately high share of the global malaria burden. Fifteen countries – mainly in sub-Saharan Africa – account for 80% of malaria cases and 78% of deaths globally.

In May 2015, the World Health Assembly adopted the Global Technical Strategy for Malaria 2016–2030. The strategy aims at a further 90% reduction in global malaria incidence and mortality by 2030. The report notes that these targets can only be achieved with political will, country leadership and significantly increased investment.

September 23, 2015
Year of publication
2015
Tags
malaria, MDGs

Similar Resources

This report presents progress made after two years of implementation of the ESA Commitment (2013-2015). Significant progress has already been made thanks to concerted action by governments, civil society, and development partners at national and regional level.

The U.S. Government is committed and working toward the goal of Ending Preventable Child and Maternal Deaths (EPCMD) in a generation. In June of 2014, the U.S.

Donor funding for HIV programs has flattened out in recent years, which limits the ability of HIV programs worldwide to achieve universal access and sustain current progress. This study examines alternative mechanisms for resource mobilization.

The Xpert MTB/RIF assay is an accurate test for the diagnosis of tuberculosis when an adequate sputum sample can be obtained; even in smear-negative tuberculosis the sensitivity is about 67%. Although the assay turnaround time is under 2 h, depending on the health-care setting, time to…

OBJECTIVES: To evaluate the global and country-level burden of HIV/AIDS relative to 291 other causes of disease burden from 1980-2010 using the Global Burden of Disease Study 2010 (GBD 2010) as the vehicle for exploration.

The United States is the world’s leading donor in global health.

By telling the stories of four inspiring individuals, EXPOSED brings viewers to the forefront of the race against tuberculosis. Watch the four-part series of short films on the global TB epidemic and the race to develop new tools to prevent it.

The main focus of this report is to review the risk factors for HIV among sex workers in sub-Saharan Africa, and the interventions that have been successfully implemented in this region.

Depuis le taux de fécondité des adolescentes jusqu’aux sommes dépensées pour la santé par les gouvernements, les Statistiques sanitaires mondiales ont réponse à toutes vos questions sur la santé des populations dans le monde.

World Health Statistics 2012 contains WHO’s annual compilation of health-related data for its 194 Member States, and includes a summary of the progress made towards achieving the health-related Millennium Development Goals (MDGs) and associated targets.